1578-1579 / 2063
T-cell priming
•
Agonistic antibodies directed against costimulatory
molecules on T-cells and/or blocking antibodies
against coinhibitory molecules to increase T-cell
function
•
E.g. CTLA-4 blockade
(ipilimumab)
Ribas, NEJM 2015
Herrera FG et al CA Cancer J Clin 2017